Author:
Argikar Upendra A.,Potter Philip M.,Hutzler J. Matthew,Marathe Punit H.
Publisher
Springer Science and Business Media LLC
Reference125 articles.
1. Garattini E, Terao M. Increasing recognition of the importance of aldehyde oxidase in drug development and discovery. Drug Metab Rev. 2011;43(3):374–86. doi: 10.3109/03602532.2011.560606 .
2. Terao M, Romao MJ, Leimkuhler S, Bolis M, Fratelli M, Coelho C, et al. Structure and function of mammalian aldehyde oxidases. Arch Toxicol. 2016;90(4):753–80. doi: 10.1007/s00204-016-1683-1 .
3. Beedham C. Molybdenum hydroxylases: biological distribution and substrate-inhibitor specificity. Prog Med Chem. 1987;24:85–127.
4. Kitamura S, Sugihara K, Ohta S. Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab Pharmacokinet. 2006;21(2):83–98.
5. Sugihara K, Kitamura S, Tatsumi K. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug Metab Dispos. 1996;24(2):199–202.
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献